These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Clostridium difficile infection frequency in patients with nosocomial infections or using antibiotics. Gursoy S; Guven K; Arikan T; Yurci A; Torun E; Baskol M; Ozbakir O; Yucesoy M Hepatogastroenterology; 2007 Sep; 54(78):1720-4. PubMed ID: 18019703 [TBL] [Abstract][Full Text] [Related]
46. Alternative therapies for Clostridium difficile infections. Venuto C; Butler M; Ashley ED; Brown J Pharmacotherapy; 2010 Dec; 30(12):1266-78. PubMed ID: 21114394 [TBL] [Abstract][Full Text] [Related]
47. Fidaxomicin: a macrocyclic antibiotic for the management of Clostridium difficile infection. Sullivan KM; Spooner LM Ann Pharmacother; 2010 Feb; 44(2):352-9. PubMed ID: 20071495 [TBL] [Abstract][Full Text] [Related]
48. Clostridium difficile. Heywood S Nurs Stand; 2007 Nov 28-Dec 4; 22(12):59. PubMed ID: 18087880 [No Abstract] [Full Text] [Related]
49. Editorial: Clostridium difficile infection: Yet another predictor of poor outcome in cirrhosis. Garcia-Tsao G; Surawicz CM Am J Gastroenterol; 2010 Jan; 105(1):114-6. PubMed ID: 20054307 [TBL] [Abstract][Full Text] [Related]
50. [Some aspects of the Clostridium difficile infection]. Wójtowicz A Wiad Lek; 1998; 51(7-8):360-7. PubMed ID: 9748892 [TBL] [Abstract][Full Text] [Related]
51. Chemoprophylaxis in the prevention of Clostridium difficile infection: Still a ways to go. Tobar-Marcillo M; Guerrero-Durán M; Basante-Díaz R Rev Gastroenterol Mex; 2017; 82(4):361-362. PubMed ID: 28844313 [No Abstract] [Full Text] [Related]
52. Continued high use of PPIs despite C. difficile risk. Brown C CMAJ; 2014 Dec; 186(18):1350. PubMed ID: 25384647 [No Abstract] [Full Text] [Related]
53. Strategies to prevent and control Clostridium difficile: one hospital's account. Young A; Barbella H; Novack S; Campbell PA Pa Nurse; 2007 Dec; 62(4):24-5. PubMed ID: 18286843 [No Abstract] [Full Text] [Related]
54. Clostridium difficile: emerging public health threat and other nosocomial or hospital acquired infections. Introduction. McFee RB Dis Mon; 2009 Jul; 55(7):419-21. PubMed ID: 19540994 [No Abstract] [Full Text] [Related]
56. Proton Pump Inhibitors and Clostridium difficile Infection. Goyal H; Katner H Am J Gastroenterol; 2017 May; 112(5):805. PubMed ID: 28469228 [No Abstract] [Full Text] [Related]
57. Decline in incidence of Clostridium difficile infection after relocation to a new hospital building with single rooms. Heddema ER; van Benthem BH J Hosp Infect; 2011 Sep; 79(1):93-4. PubMed ID: 21641679 [No Abstract] [Full Text] [Related]
58. OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection. Louie TJ; Emery J; Krulicki W; Byrne B; Mah M Antimicrob Agents Chemother; 2009 Jan; 53(1):261-3. PubMed ID: 18955523 [TBL] [Abstract][Full Text] [Related]
59. Treating C. difficile. Johnston BC; Vohra S CMAJ; 2005 Feb; 172(4):447-8. PubMed ID: 15710916 [No Abstract] [Full Text] [Related]